Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.

High-yield dividend stocks may not appeal to some investors. Three Motley Fool contributors have identified some especially great high-yield dividend stocks to buy in 2025 -- and all of them are big ...

The oral Nurtec (rimegepant) and Qulipta (atogepant) drugs are also considered first-line preventive care for migraine symptoms. Additionally, Nurtec, Ubrelvy (ubrogepant), and Zavzpret (zavegepant)—a ...

The company raised its full-year revenue and EPS guidance, reflecting robust performance across key products like Venclexta, Vraylar, Ubrelvy, and Qulipta. AbbVie also completed the acquisition of ...

The company raised its full-year revenue and EPS guidance, reflecting robust performance across key products like Venclexta, Vraylar, Ubrelvy, and Qulipta. AbbVie also completed the acquisition of ...

But a recently approved daily migraine pill called Qulipta (atogepant) appears to be effective from day one in many patients, clinical trial data shows. Patients taking Qulipta had a 37% to 61% ...

“With many current drugs to prevent migraine, it takes time to find the right dosage for the individual and it can take weeks or even months for it to be most effective,” lead researcher Dr. Richard ...